Accardi Mario Alberto Insider Trades

Insider Trading History

Track insider trading activity for Accardi Mario Alberto. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Executive Officer
Holding Value $9.69M 243,282 shares
Last Trade
May 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$23.8k 604 shares
$39.42
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Executive Officer
Holding Value $10.9M 273,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.59M 341,000 shares
$25.19
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Executive Officer
Holding Value $7.01M 175,886 shares
Last Trade
Feb 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$71.6k 2,915 shares
$24.57
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $7.23M 181,369 shares
Last Trade
Dec 09, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$288k 10,000 shares
$28.83
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $7.92M 198,801 shares
Last Trade
Dec 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$150k 5,000 shares
$29.91
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $7.52M 188,801 shares
Last Trade
Dec 08, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$300k 10,000 shares
$30.00
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $249k 6,250 shares
Last Trade
Dec 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$150k 5,000 shares
$29.91
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $7.72M 193,801 shares
Last Trade
Nov 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.8k 593 shares
$24.90
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $7.75M 194,394 shares
Last Trade
Oct 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$200k 8,000 shares
$25.00
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $1.2M 30,000 shares
Last Trade
Oct 27, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 5,000 shares
$24.46
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $8.07M 202,394 shares
Last Trade
Oct 27, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 5,000 shares
$24.46
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $7.9M 198,136 shares
Last Trade
Sep 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$175k 8,172 shares
$21.39
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $1.39M 35,000 shares
Last Trade
Sep 09, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$104k 5,000 shares
$20.85
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $8.47M 212,566 shares
Last Trade
Sep 09, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$104k 5,000 shares
$20.85
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $8.19M 205,566 shares
Last Trade
Sep 09, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$140k 7,000 shares
$20.00
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $8.27M 207,566 shares
Last Trade
Aug 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$10.3k 597 shares
$17.17
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $8.3M 208,163 shares
Last Trade
Jul 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$127k 8,322 shares
$15.23
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $9.22M 231,485 shares
Last Trade
Jun 24, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$213k 15,000 shares
$14.20
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $8.63M 216,485 shares
Last Trade
Jun 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$210k 15,000 shares
$14.00
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
President, Orexin Program
Holding Value $610k 15,300 shares
Last Trade
Jun 24, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$213k 15,000 shares
$14.20
$39.85

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up